ERp29 forms a feedback regulation loop with microRNA-135a-5p and promotes progression of colorectal cancer.

ERp29 forms a feedback regulation loop with microRNA-135a-5p and promotes progression of colorectal cancer.
复制标题

ERp29与microRNA-135a-5p形成反馈调节环,促进结直肠癌进展

DOI:
10.1038/s41419-021-04252-z
复制
发表时间:
2021-10-19
影响因子:
9
通讯作者:
Li P
Li P
中科院分区:
生物学1区
文献类型:
--
作者:
Huang J;Jing M;Chen X;Gao Y;Hua H;Pan C;Wu J;Wang X;Chen X;Gao Y;Xu C;Li P

文献摘要

参考文献

被引文献

相似文献

内质网(ER)应激相关基因的表达往往在癌症进展中失调。ER蛋白29(ERp 29)在多种肿瘤中异常表达,在肿瘤发生中起重要作用。在此,我们发现ERp 29是microRNA-135 a-5 p(miR-135 a-5 p)抑制结直肠癌(CRC)进展的新靶点;相应地,ERp 29作为癌蛋白在CRC中通过促进CRC细胞的增殖和转移以及抑制细胞的凋亡而起作用。更重要的是,我们发现ERp 29通过抑制IL-1β诱导的miR-135 a-5 p启动子区域甲基化来反向上调miR-135 a-5 p表达,这是肠细胞维持miR-135 a-5 p和ERp 29之间平衡的过程,但在CRC中失调。我们的研究揭示了miR-135 a-5 p和ERp 29之间的一种新的反馈调节环,这对维持它们各自的适当水平至关重要,但在CRC中部分失衡,导致miR-135 a-5 p和ERp 29的异常表达,这进一步加速了CRC的进展。我们为ERp 29和miR-135 a-5 p作为CRC诊断和治疗的潜在生物标志物提供了支持证据。
Expression of endoplasmic reticulum (ER) stress-associated genes is often dysregulated in cancer progression. ER protein 29 (ERp29) is abnormally expressed in many neoplasms and plays an important role in tumorigenesis. Here, we showed ERp29 is a novel target for microRNA-135a-5p (miR-135a-5p) to inhibit the progression of colorectal cancer (CRC); correspondingly, ERp29 acts as an oncoprotein in CRC by promoting proliferation and metastasis of CRC cells, and suppressing apoptosis of the cells. More importantly, we found that miR-135a-5p expression is reversely upregulated by ERp29 through suppressing IL-1β-elicited methylation of miR-135a-5p promoter region, a process for enterocyte to maintain a balance between miR-135a-5p and ERp29 but dysregulated in CRC. Our study reveals a novel feedback regulation loop between miR-135a-5p and ERp29 that is critical for maintaining appropriate level of each of them, but partially imbalanced in CRC, resulting in abnormal expression of miR-135a-5p and ERp29, which further accelerates CRC progression. We provide supporting evidence for ERp29 and miR-135a-5p as potential biomarkers for diagnosis and treatment of CRC.
DOI: 10.1016/s0014-5793(96)01513-x
发表时间: 1997-02-03
期刊: FEBS LETTERS
影响因子: 3.5
作者:
Demmer, J;Zhou, CM;Hubbard, MJ
通讯作者: Hubbard, MJ
DOI: 10.1016/j.immuni.2018.11.015
发表时间: 2019-01-15
期刊: IMMUNITY
影响因子: 32.4
作者:
Dmitrieva-Posocco, Oxana;Dzutsev, Amiran;Grivennikov, Sergei, I
通讯作者: Grivennikov, Sergei, I
DOI: 10.1093/nar/30.1.38
发表时间: 2002-01-01
影响因子: 14.9
作者:
Hubbard, T;Barker, D;Clamp, M
通讯作者: Clamp, M
DOI: 10.1186/s12935-020-1123-4
发表时间: 2020-02-18
影响因子: 5.8
作者:
Feng, Lei;Lin, Tao;Wang, Xiaoming
通讯作者: Wang, Xiaoming
DOI: 10.3892/or.2018.6943
发表时间: 2019-03-01
期刊: ONCOLOGY REPORTS
影响因子: 4.2
作者:
Guo, Lili;Ma, Lili;Deng, Yongjian
通讯作者: Deng, Yongjian